Tachyarrhythmia in patients with congenital heart disease: inevitable destiny? by Teuwen, C.P. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/171611
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Review ARticle
Published online: 4 January 2016
© The Author(s) 2015. This article is published with open access at Springerlink.com
Tachyarrhythmia in patients with congenital heart disease: 
inevitable destiny?
C.P. Teuwen · Y.J.H.J. Taverne · C. Houck · M. Götte · B.J.J.M. Brundel · R. Evertz · M. Witsenburg ·  
J.W. Roos-Hesselink · A.J.J.C. Bogers · N.M.S. de Groot · DANARA Study Investigators
Neth Heart J (2016) 24:161–170
DOI 10.1007/s12471-015-0797-z
aim of this review is to discuss the present knowledge 
on the mechanisms underlying both atrial and ventricular 
tachyarrhythmia in patients with CHD and the advantages 
and disadvantages of the currently available invasive treat-
ment modalities.
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Introduction
Congenital heart disease (CHD) is defined as a developmen-
tal malformation of the heart chambers, valves or great ves-
sels. The incidence of newborns with CHD has increased 
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over the last century from 0.6 per 1000 live births in 1930, 
to 9.1 per 1000 live births after 1995, thereby making CHD a 
major public health issue [1]. This development is caused by 
more accurate registration procedures and improved diag-
nostic tools (e.g. cardiac imaging techniques). However, 
there are still geographical differences in the prevalence 
of CHD birth rates, which can be explained by e.g. genetic 
or environmental factors [1]. The number of adult CHD 
patients has also increased in the past decades, as nowa-
days over 90 % of paediatric patients survive into adulthood 
due to improved clinical care and surgical techniques [2]. 
Although survival of CHD patients has been significantly 
prolonged, many of them frequently experience complica-
tions such as rhythm disorders by the time they reach adult-
hood [3]. These postoperative dysrhythmias may cause a 
wide range of symptoms, ranging from palpitations to even 
sudden cardiac death.
Many of these late postoperative tachyarrhythmias are, 
however, insufficiently controlled by antiarrhythmic drugs 
[4]. A lifetime usage of class III antiarrhythmic drugs such 
as amiodarone may result in less recurrences [5], but also 
increases the risk of adverse effects in the relatively young 
adult CHD patient, particularly in women with CHD, cya-
notic patients and patients with a Fontan circulation [6]. 
Atrial pacing in order to prevent tachyarrhythmias is often 
not effective[7]. However, endovascular catheter ablation 
has arisen since the 1990s and both short- and long-term 
outcomes are promising [8].
Most studies reporting on late postoperative tachyar-
rhythmias in CHD patients described the incidence of the 
various types of tachyarrhythmia, the outcome of different 
treatment modalities, and in case of ablative therapy, the 
mechanism of the tachyarrhythmia and the location of suc-
cessful target sites for catheter ablation in small groups of 
patients with a variety of CHD. The purpose of this review 
is to outline the present knowledge of the mechanisms 
underlying atrial and ventricular tachyarrhythmia in CHD 
patients and to discuss the advantages and limitations of the 
currently available invasive treatment modalities.
Atrial macro reentrant tachycardia
Atrial macro-reentrant tachycardias are the most frequently 
reported atrial tachyarrhythmias in patients with both 
repaired and unrepaired CHD. They can be classified as 
either an intra-atrial reentrant tachycardia (IART) or typical 
clockwise and counterclockwise atrial flutter (AFL) which 
also occurs in patients without CHD [3, 9–12]. Most macro-
reentry circuits in CHD patients are located within the right 
atrium [8]. The incidence of typical AFL has mainly been 
observed in patients with tetralogy of Fallot (ToF) or atrial 
septal defect (ASD) [10, 12–14]. AFL is caused by a macro-
reentrant circuit located within the right atrium (Fig. 1) 
and it is bordered by the tricuspid annulus (anteriorly), 
the orifices of the superior and inferior caval vein (Eusta-
chian ridge, posteriorly), the coronary sinus and the crista 
terminalis. The smallest pathway within the reentry circuit 
is the cavotricuspid isthmus, which is often a zone of slow 
conduction. Typical counterclockwise AFL waves on the 
surface electrocardiogram (left panel of Fig. 2) consist of 
a slowly descending component, rapid negative deflection, 
Fig. 2 ECG characteristics of regular atrial tachycardias. Left panel: 
typical atrial flutter consisting of flutter waves with 1) flat descending 
part, 2) steep descending transition, 3) sharp upstroke and 4) a minor 
overshoot. Right panel: intra-atrial reentrant tachycardia; the four 
characteristics of the typical flutter waves are missing
 
Fig. 1 Anatomy of the cavotricuspid isthmus. Postmortem human 
heart with a superolateral view of the right atrium (turned inside out) 
with a bicaval incision. The cavotricuspid isthmus, which is regarded 
as the zone of slow conduction, is encircled. The isthmus is bordered 
anteriorly by the TA and posteriorly by the orifice of the ICV. CS coro-
nary sinus, CTI cavotricuspid isthmus, ICV inferior vena cava, TA tri-
cuspid annulus
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after surgical correction commonly function as crucial path-
ways of conduction (Fig. 3).
Reentry circuits have also been found in the left atrium, 
though less frequently. They have been observed in patients 
with ASD, TGA, univentricular heart and ToF, but descrip-
tions of the exact pathways have not been given [12, 18].
Although an ECG might provide a clue about the path-
way of the reentrant wavelet, invasive electrophysiological 
studies are essential to determine the underlying mecha-
nism of the arrhythmia and to identify the crucial pathway 
of conduction [19]. Endovascular catheter ablation is then 
aimed at transecting this pathway in order to terminate the 
tachyarrhythmia.
Initial ablation procedures of postoperative atrial tachy-
cardia in CHD patients were guided by fluoroscopy only 
[20]. Target sites for ablation were solely selected by using 
entrainment mapping techniques. However, selection of the 
appropriate target site for ablation was difficult as it required 
an imaginary three-dimensional (3D) reconstruction of the 
(multiple) reentrant circuits in a complex cardiac anatomy. 
The success rate often depended on the complexity of the 
underlying heart defect [8, 20].
The introduction of 3D electroanatomical mapping tech-
niques enabled 3D visualisation of the patterns of activa-
tion (Fig. 4), thereby facilitating selection of appropriate 
target sites for ablation. The use of this technology resulted 
in improved outcomes of ablative therapy [18]. In addition 
to this, new techniques facilitated navigation to the target 
site and the usage of irrigated tip catheters improved lesion 
formations and further increased the success rate [21–23]. 
Although catheter ablation with a success rate of 90 % has 
been reported, ablation of IART is less successful than that 
sharp upstroke and minor overshoot [15]. Catheter ablation 
is aimed at creating a linear lesion across the cavotricuspid 
isthmus which establishes a line of conduction block which 
in turn interrupts the reentrant wavelet.
All other atrial reentry tachycardias, not using the reen-
try circuit of typical AFL in either the right or left atrium, 
are defined as IART and have frequently been described in 
patients with a univentricular heart and transposition of the 
great arteries (TGA) [12, 16]. The cavotricuspid isthmus 
may still be part of the reentry circuit, but the reentry wave-
let may circulate around other structures, such as areas of 
scar tissue, surgically inserted material or suture lines [17]. 
The reentrant wavelet in the atria of CHD patients can often 
follow different pathways due to the presence of multiple 
corridors between patchy areas of scar tissue, anatomical 
structures or surgically inserted material [18]. As demon-
strated by the surface ECG in the right panel of Fig. 2, the 
four characteristics of typical flutter waves are usually not 
present.
Reentry pathways of IARTs described in literature are 
highly variable. The right atriotomy scar, creating crucial 
pathways of conduction between the right atriotomy site and 
the inferior caval vein, is often involved in IART [10–12, 
18]. In patients with a univentricular heart or TGA, areas of 
slow conduction have been found along inserted prosthetic 
materials such as the Fontan conduit or intra-atrial baffles 
after the Senning or Mustard procedure [8, 10, 18]. Further-
more, regions around the septal patch in patients with ASD 
Fig. 4 Electroanatomical mapping of IART. Three-dimensional elec-
troanatomical mapping of the right atrium in a 15-year-old patient, 12 
years after completion of the Fontan correction, who was referred for 
ablative therapy of an incessant atrial tachycardia. The colour-coded 
right atrial activation map shows a figure-of-eight reentry around 2 
areas of scar tissue. The tachycardia was eliminated by constructing a 
linear lesion between 2 areas of scar tissue
 
Fig. 3 Anatomy of heart with CHD. Postmortem human heart of a 
4-year-old child with a large atrial septal defect. The heart is shown 
from a lateral view through a right atriotomy incision into the right 
atrium. In adult patients with congenital heart defects, the intra atrial 
reentry tachycardia is frequently observed around the right atriotomy 
scar (red marked area), but also around the atrial septal defect (yellow 
marked area). ASD atrial septal defect, CS coronary sinus, ICV infe-
rior caval vein, RAA right atrial appendage, RV right ventricle, SCV 
superior caval vein
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only and invasive electrophysiological studies are therefore 
crucial to correctly diagnose the underlying mechanism.
Several studies demonstrated that the origins of focal 
atrial tachycardia were located along the borders of areas of 
scar tissue. Although areas of scar tissue are found scattered 
throughout both the right and left atrium in patients with 
CHD, they mainly originate from the right atrium [10, 24].
Theoretically, focal atrial tachycardia can be caused by 
enhanced automaticity, triggered activity or micro-reentry 
[25]. De Groot et al. observed prolonged fractionated poten-
tials at the origins of focal atrial tachycardia reflecting local 
dissociation in conduction suggestive of micro-reentry as 
the underlying mechanism [10].
The success rate of ablative therapy of focal atrial tachy-
cardia in patients with a variable complexity of CHD was 
high (86–100 %) [10, 26]. However, comparable with atrial 
reentry tachycardia, ‘recurrences’ of atrial tachyarrhythmia 
after ablation of focal atrial tachycardia have been reported. 
Most atrial tachycardia developed within three years or 
even less and was mainly caused by other mechanisms (e.g. 
IART) [24].
Atrial fibrillation
Atrial fibrillation (AF) is less frequently observed in CHD 
patients than regular atrial tachycardia [27, 28]. Whereas abla-
tive therapy is nowadays an accepted treatment modality for 
regular atrial tachycardia in CHD patients, endovascular cath-
eter ablation of AF in CHD patients is less well established. In 
addition to this, it is unknown whether the mechanism underly-
ing AF in CHD patients is comparable with patients without 
CHD. The lifetime pressure and stretch may lead to sinus node 
dysfunction and increased ectopy (triggers) that initiate atrial 
tachyarrhythmias [29]. The overload may result in fibrosis and 
of AFL. This may be due to e.g. insufficient lesion depth 
in the thickened atrial wall or conversion from one atrial 
tachycardia to another during ablation due to the presence 
of multiple pathways.
Despite successful procedural outcome of catheter abla-
tion, atrial tachycardia recurs frequently. The reentry circuit 
and subsequently the crucial pathway of conduction may be 
located at the same site of the previous ablation [8], but they 
have often been found at other sites [24]. Recurrences of 
atrial tachycardia may also be caused by different mecha-
nisms. For example, a focal atrial tachycardia may develop 
after successful ablation of IART [24]. The arrhythmogenic 
substrate of recurrences was often located at other atrial 
sites, indicating that the atrial tachycardia was not related 
to the previous tachycardia. These ‘recurrent’ tachycar-
dias after ablative therapy may simply reflect a progressive 
cardiomyopathy caused by the persisting pressure/volume 
overload in CHD patients after cardiac surgery. This on-
going remodelling process affects intra-atrial conduction, 
thereby creating a new arrhythmogenic substrate facilitating 
development of other tachyarrhythmias.
Focal atrial tachycardia
Focal atrial tachycardias are defined as arrhythmias originat-
ing from a small, circumscribed area from where it expands 
to the remainder of the atria and have been observed in vari-
ous types of CHD (Fig. 5; [10, 11, 13]).
Expansion of the wavefront from its site of origin through 
multiple areas of conduction delay can bridge the diastolic 
interval thereby giving rise to flutter waves on the surface 
ECG. Hence, differentiation between a focal atrial tachy-
cardia and an IART may be difficult using the surface ECG 
Fig. 5 Electroanatomical map-
ping of focal atrial tachycardia. A 
17-year -old patient with patent 
foramen ovale presented with par-
oxysmal episodes of regular atrial 
tachycardia. During an invasive 
electrophysiological study with 
3D activation mapping, the atrial 
tachycardia (cycle length 348 ms) 
had a focal origin at the left atrial 
free wall. The map shows expan-
sion from one circumscribed area 
in the anterior-posterior view 
(AP) to the remainder of the 
atrium in the posterior-anterior 
view (PA). After construction of a 
circular lesion around the earliest 
activated area, the tachycardia 
terminated
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Atrioventricular reentry tachycardia
Although less common than other supraventricular tachy-
cardia, atrioventricular reentry tachycardia (AVRT) due 
to accessory bundles in CHD patients has been described, 
especially in patients with Ebstein anomaly [36]. More-
over, approximately half of these patients have multiple 
accessory bundles which often have antegrade and retro-
grade conduction. Antegrade fast conduction during atrial 
tachyarrhythmias can lead to life-threatening arrhythmias 
of the ventricles. Catheter ablation is used to interrupt the 
accessory pathway in both children and adults with CHD. 
However, the possibility of multiple accessory bundles and 
defiant morphology of the heart with abnormal endocardial 
electrograms makes successful ablative therapy more chal-
lenging [36]. If catheter ablation is unsuccessful, surgical 
treatment of the accessory bundles might be an alternative 
[37].
Ventricular tachycardia
Ventricular tachycardia (VT) also develops in patients with 
CHD, although with a lower prevalence than atrial tachyar-
rhythmias. Scars in the ventricular wall caused by surgical 
procedures or implantation of septal patches may form bor-
ders of complex reentry circuits thereby facilitating devel-
opment of reentry tachycardias [38]. However, VT also 
occurs in CHD patients who have not undergone surgery 
[39]. Therefore, next to suture lines impairing ventricular 
conduction, other mechanisms may be involved as well. 
Structural alterations such as increment in fibrotic tissue or 
myocyte hypertrophy due to volume overload may result in 
conduction abnormalities, giving rise to VT [40, 41]. Car-
diac magnetic resonance imaging can be useful to identify 
the substrate underlying the VT [42].
VT have mainly been described in patients with ToF, but 
also in patients with other CHD such as aortic valve dis-
ease, pulmonary valve stenosis, VSD and TGA [40, 43]. The 
consequences of VT are severe and may result in syncope 
and even sudden cardiac death. Effective management of 
this tachyarrhythmia is therefore essential. According to the 
European guidelines, an implantable cardioverter defibril-
lator (ICD) is indicated and recommended in patients with 
ventricular fibrillation or sustained VT with unsuccessful 
catheter ablation therapy [44]; earlier studies have shown 
that appropriate shocks occur in around 25–30 % of these 
CHD patients with an ICD [45]. Unfortunately, inappropri-
ate shocks occur frequently as well (up to 40 %) [45]. On top 
of that, an ICD implantation appears to have a great impact 
on the quality of life in these patients [46]. Primary pre-
vention of sudden cardiac death remains challenging and is 
mostly based on multiple additional determinants such as 
thereby conduction disorders which are likely to form a sub-
strate for arrhythmias such as AF and regular atrial tachycardia. 
In a recent study including 199 patients with various CHD, it 
was indeed shown that AF and regular atrial tachycardia co-
exist [27]. De Groot et al. found that a surface ECG resembling 
AF in two patients was the result of continuous electrical activ-
ity within a circumscriptive area at the right atrial posterosep-
tal and the anterolateral free wall [10]. Isolation of these areas 
by ablative therapy terminated AF. In line with these findings, 
Takahashi et al. also demonstrated that AF was the result of 
continuous fractionated electrical activity in the right atrial free 
wall and lower interatrial septum [30]. After ablation of these 
sites, the patient converted to sinus rhythm.
Endovascular pulmonary vein isolation (PVI) has been 
described in a limited number of patients. Four patients 
with an ASD and either paroxysmal (N = 2) or persistent 
(N = 2) AF were scheduled for percutaneous closure of the 
ASD [31]. Prior to closure, endovascular PVI was per-
formed in all 4 patients; additional lesions were created in 
the 2 patients with persistent AF including a circular lesion 
around the superior caval vein and a linear lesion connect-
ing the right and left pulmonary veins and mitral isthmus 
line. A recurrent AF episode occurred in only 1 patient after 
a follow-up period of 21 months in the early postopera-
tive period after an orthopaedic surgical operation and was 
controlled with antiarrhythmic drug therapy (dronedarone). 
Philip et al. performed PVI in 36 patients with CHD (ASD, 
ventricular septal defect (VSD), ASD and VSD, ToF, dou-
ble outlet left ventricle and TGA, coarctation of the aorta, 
Ebstein anomaly, and Bland-Garland White syndrome) with 
paroxysmal (n = 26) or persistent (n = 10) AF. After a mean 
follow-up period of 4 years, freedom of AF was achieved in 
27 % [32].
In patients with CHD and AF, the Cox-Maze technique 
has been applied since the 1990s. A right-sided Maze proce-
dure was performed in 77 CHD patients with preoperative 
AF (left atrial size < 41 mm) [33]. After a follow-up period 
of 2.7 years, 90 % (n = 56) of the patients were free from 
AF. However, other studies showed higher recurrence rates 
of AF in CHD patients who underwent only a right-sided 
Maze procedure compared with patients with a right- and 
left-sided Maze. Im et al. reported sinus rhythm without 
episodes of atrial tachyarrhythmias or pacemaker implanta-
tion in 69 % of the patients with right- and left-sided Maze 
procedure after 5 years of cardiac surgery compared with 
only 45 % of the patients with a right-sided Maze [34]. 
Moreover, recurrences of AF seem to be rare in other stud-
ies when antiarrhythmic surgery includes the right and left 
atrium, suggesting that the left atrium plays a (major) role 
in the pathophysiology of AF in patients with CHD as well 
[35]. Altogether, a concomitant Maze procedure should be 
considered in CHD patients known with AF who undergo 
corrective/palliative surgery at adult age.
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be considered. The possibility of multiple arrhythmias and 
previous, failed invasive procedures should be taken into 
account in order to estimate the success rate of ablative 
therapy. Yet, after successful ablative therapy new tachycar-
dias continue to develop. Insight into the development of 
these recurrent tachycardias is essential in order to develop 
preventive strategies. Another challenge is to elucidate the 
mechanism of AF in this study population, as the incidence 
of AF continues to rise in this ageing population. In order to 
gain further insight into the pathophysiology of dysrhyth-
mias, we initiated an international multicentre study (DAN-
ARA project) focussing on development of dysrhythmias in 
patients with CHD by correlating the occurrence of arrhyth-
mias over time in relation to clinical profiles. In addition, 
we perform intra-operative high resolution mapping studies 
in order to examine the arrhythmogenic substrate. With this 
project, we hope to improve our comprehension of these 
complex, but ever-challenging arrhythmias.
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